China

CIRS RD Briefing 84 – China’s evolving regulatory landscape

China has made significant changes to its medicine regulatory system including: Regulatory reforms - since 2015, regulatory reforms have helped to eliminate application backlogs, improve review timelines and increase [...]

Jenny Sharpe2024-04-12T09:05:39+00:00May 4th, 2022|Tags: China, Regulatory|

CIRS RD Briefing 56: Understanding the dynamics of China’s regulatory environment

Changes have occurred in the organisation and procedural activities of the China Food and Drug Administration (CFDA) and the Centre for Drug Evaluation (CDE). Initiatives that were designed to [...]

Jenny Sharpe2022-05-04T09:06:07+00:00June 1st, 2015|Tags: APAC, China, Regulatory|